==inizio objective==
According to the most recent guidelines, the percutaneous nephrolithotomy (PCNL) is the standard procedure for large renal stones(1). Intraoperative and postoperative bleedings are common complications associated with PCNL(2).
Sometimes PCNL procedures have to be interrupted if a severe intraoperative hemorrhage occurs. Mild bleedings after PCNL may be treated by brief clamping of the nephrostomy tube and adequate hydration. The superselective embolization of the segmental renal artery may become necessary in the case of severe bleedings. When embolization fails, urgent open exploration with an high probability of nephrectomy may become necessary. Sometimes a postoperatively bleeding may occurs at the time of nephrostomic tube removal(3). Hemostatic agents are usually used for nephrostomy tract closure after tubeless PCNL(4) but they are not described in scientific literature as devices usefull at the time of nephrostomic tube removal. The aim of this study was to evaluate our series of haemorrhagic complications during PCNL procedures and to descrive our experience in the use of the hemostatic agents at the time of nephrostomic tube removal.
==fine objective==
==inizio methodsresults==
From January 2010 to January 2015, 481 patients underwent a PCNL procedure at our department. 477 procedures were performed in a prone position and 4 procedures were performed in a supine position. A standard access tract (24-30 Fr) was used in 476 (99%) patients. The nephrostomy access was commonly achieved with the telescoping metal dilators of Alken. The pneumatic balloon dilator (Nephromax®) was used in 52 patients (10,8%). Stone fragmentation was achieved with the use of an ultrasonic device or a combined ultrasound/pneumatic lithotrite device. 16 out of 481 (3,3%) patients underwent a totally tubeless PCNL and “FloSeal® Hemostatic Matrix” was used for nephrostomy tract closure in 7 procedures (43,8%). In the standard procedures a 5-Fr-ureteral catheter was placed at the beginning of the procedure and a modified 20-Fr-Foley catheter was placed at the end of the procedure as nephtrostomic tube.
==fine methodsresults==
==inizio results==
Severe intraoperative bleedings occurred in 13 patients (2,7%) and in 2 patients (0,4%) we had to interrupt the procedure. Postoperative bleedings occurred in 39 patients (8,1%). 32 out of 39 bleedings (82,1%) were mild and were solved by clamping of the nephrostomy tube and adequate hydration. 7 out of 39 bleedings (17,9%) were severe and the patients underwent a diagnostic angiography. Of these, 5 patients underwent a superselective embolization of a vascular lesions or a pseudoaneurysm (Image 1) and 2 patients experienced a spontaneous endogenous hemostasis during angiography, probably due to a vasospasm(5). 8 out of 481 patients (1,7%) underwent blood transfusions for severe anemia. Postoperatively bleedings at the time of nephrostomic tube removal occurred in 14 patients (2,9%). In 2 patients (14,3%) we have repositioned the nephrostomic tube. In 1 patient (7,1%) haemostasis was achieved with the help of “TachoSil® Medicated Sponge” and in 11 patients (78,6%) with the help of “FloSeal® Hemostatic Matrix”.
==fine results==
==inizio discussions==
Most common risk factors for severe bleedings are described in scientific literature: upper caliceal puncture, solitary kidney, staghorn stone, kidney inflammation, multiple punctures, angular movement in order to search distal caliceal stone and inexperienced surgeon(6). Additional risk factors shown to increase the risk of bleeding during or after PCNL include diabetes mellitus, prolonged operative time, utilization of a mature nephrostomy tract, concomitant surgical complications, modality of access guidance (ultrasound versus fluoroscopic), and access tracts which traverse atrophic parenchima(7),(8). In our opinion the right planning of the procedure and the surgeon experience can reduce the hemorrhagic complications during a PCNL. In our series the intraoperative bleeding complication rate was very low and severe postoperative bleedings occurred only in 1,5% of the patients. Moreover the blood transfusion rate was similar to the most important series in scientific literature(9).
==fine discussions==
==inizio conclusion==
PCNL is the standard procedure for large renal stones. PCNL is a feasible procedure with a low rate of intraoperative and postoperative complications in high volume centers. Despite this, during the procedure, hemorrhagic complications can occur, in particular in some categories of patients or when the procedure is particularly difficult. In our opinion, surgeon experience and the right planning of the procedure can reduce the hemorrhagic complications during a PCNL. The “FloSeal® Hemostatic Matrix”, commonly used for nephrostomy tract closure after tubeless PCNL, is an useful device in the management of postoperative bleedings at the time of nephrostomic tube removal.
==fine conclusion==
==inizio references==
1- C. Türk , T. Knoll, A. Petrik, K. Sarica, A. Skolarikos, M. Straub, C. Seitz, Guidelines on Urolithiasis, 2015.
2- Seitz C, Desai M, Hacker A, Hakenberg OW, Liatsikos E, Nagele U, Tolley D. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol 2012 Jan;61(1):146-58
3- Ruoppolo M, Bellorofonte C, Dell’Acqua S, Zaatar C, Ferri PM, Tagliaferri A, Tombolini P.Complications of percutaneous litholapaxy. Arch Ital Urol Nefrol Androl. 1990 Dec;62(4):399-410.
4-Yu C, Xu Z, Long W, Longfei L, Feng Z, Lin Q, Xiongbing Z, Hequn C. Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis. Urolithiasis. 2014 Oct;42(5):445-53. doi: 10.1007/s00240-014-0687-7. Epub 2014 Jul 27.
5- Yuan KC, Wong YC, Lin BC, Kang SC, Liu EH, Hsu YP. Negative catheter angiography after vascular contrast extravasations on computed tomography in blunt torso trauma: an experience review of a clinical dilemma. Scand J Trauma Resusc Emerg Med. 2012;20(1):46.
6- El-Nahas AR, Shokeir AA, El-Assmy AM, Mohsen T, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA. Post-percutaneous nephrolithotomy extensive hemorrhage: A study of risk factors. J Urol. 2007;177:576–9.
7-Wang Y, Jiang F, Wang Y, Hou Y, Zhang H, Chen Q, Xu N, Lu Z, Hu J, Lu J, Wang X, Hao Y, Wang C. Post-percutaneous nephrolithotomy septic shock and severe hemorrhage: a study of risk factors. Urol Int 2012;88:307-10.
8-Kukreja R., Desai M., Patel S., Bapat S, Desai M. Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 2004;18:715-22.
9- Soucy F, Ko R, Duvdevani M, Nott L, Denstedt JD, Razvi H.. Percutaneous nephrolithotomy for staghorn calculi: a single center’s experience over 15 years. J Endourol 2009;23:1669-73
==fine references==